Towards multiscale modeling of influenza infection

Journal of Theoretical Biology

Volumn 332, Issue , 2013, Pages 267-290

  Murillo, Lisa N ^a   Murillo, Michael S ^a   Perelson, Alan S ^a  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

Epidemiological; Influenza A virus model; Metapopulation; Networks; Viral kinetics

Indexed keywords

ALGORITHM; EPIDEMIOLOGY; INFLUENZA; METAPOPULATION; NUMERICAL MODEL; VIRUS;

ACCURACY; ADAPTIVE IMMUNITY; ALGORITHM; COMPUTER; COMPUTER MODEL; DISEASE SEVERITY; ENDOCYTOSIS; EPIDEMIOLOGY; HOST; HUMAN; INFECTION; INFLUENZA; INFLUENZA VIRUS A; INNATE IMMUNITY; MATHEMATICAL MODEL; MOLECULAR EVOLUTION; MUCUS; MULTISCALE MODELING; NONHUMAN; PATIENT MOBILITY; POPULATION; PRIORITY JOURNAL; PUBLIC HEALTH; RECEPTOR BINDING; REVIEW; SUPERINFECTION; TEMPERATURE; THEORETICAL MODEL; VIRUS ENTRY; VIRUS LOAD; VIRUS PARTICLE; VIRUS TRANSMISSION;

EPIDEMIOLOGICAL; INFLUENZA A VIRUS MODEL; METAPOPULATION; NETWORKS; VIRAL KINETICS;

ANIMALS; EVOLUTION, MOLECULAR; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MODELS, BIOLOGICAL;

INFLUENZA A VIRUS;

EID: 84880037702     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2013.03.024     Document Type: Review

References (282)

1. Ajelli M., Goncalves B., Balcan D., Colizza V., Hu H., Ramasco J.J., Merler S., Vespignani A. Comparing large-scale computational approaches to epidemic modeling. agent-based versus structured metapopulation models. BMC Infect. Dis. 2010, 10:190.
2. Alford R.H., Kasel J.A., Gerone P.J., Knight V. Human influenza resulting from aerosol inhalation. Proc. Soc. Exp. Biol. Med. 1966, 122:800-804.
3. Amaku M., Burattini M.N., Coutinho F.A.B., Massad E. Modeling the dynamics of viral evolution considering competition within individual hosts and at population level. the effects of treatment. Bull. Math. Biol. 2010, 72:1294-1314.
4. Anderson R.M., May R.M. Infectious Diseases of Humans, Dynamics and Control 2008, Oxford University Press, Oxford, UK.
5. Andreasen V., Lin J., Levin S. The dynamics of cocirculating influenza strains conferring partial cross-immunity. J. Math. Biol. 1997, 35:825-842.
6. Anekal S.G., Zhu Y., Graham M.D., Yin J. Dynamics of virus spread in the presence of fluid flow. Integrative Biol. 2009, 1:664-671.
7. Arino O., Sanchez E., Bravo de la Parra R. A model of an age-structured population in a multipatch environment. Math. Comput. Modelling 1998, 27:137-150.
8. Axelrod R. The Complexity of Cooperation. Agent-Based Models of Competition and Collaboration 1997, Princeton University Press, Princeton, NJ, USA.
9. Baccam P., Beauchemin C., Macken C.A., Hayden F.G., Perelson A.S. Kinetics of influenza A virus infection in humans. J. Virol. 2006, 80:7590-7599.
10. Badham J., Stoker R. The impact of network clustering and assortativity on epidemic behavior. Theor. Popul. Biol. 2010, 77:71-75.
11. Balcan D., Colizza V., Goncalves B., Hu H., Ramasco J.J., Vespignani A. Multiscale mobility networks and the spatial spreading of infectious diseases. Proc. Natl. Acad. Sci. USA 2009, 106:21484-21489.
12. Bansal S., Pourbohloul B., Meyers L.A. A comparative analysis of influenza vaccination programs. PLoS Med. 2006, 3:1816-1825.
13. Baskin C.R., Bielefeldt-Ohmann H., Tumpey T.M., Sabourin P.J., Long J.P., Garcia-Sastre A., Tolnay A.E., Albrecht R., Pyles J.A., Olson P.H., Aicher L.D., Rosenzweig E.R., Murali-Krishna K., Clark E.A., Kotur M.S., Fornek J.L., Proll S., Palermo R.E., Sabourin C.L., Katze M.G. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc. Natl. Acad. Sci. USA 2009, 106:3455-3460.
14. Bauer A.L., Beauchemin C.A., Perelson A.S. Agent-based modeling of host-pathogen systems. the successes and challenges. Inf. Sci. 2009, 179:1379-1389.
15. Beauchemin C. Probing the effects of the well mixed assumption on viral infection dynamics. J. Theor. Biol. 2006, 242:464-477.
16. Beauchemin, C., Forrest, S., Koster, F.T., 2006. Modeling influenza viral dynamics in tissue. in: ICARIS, vol. 4163, pp. 23-36.
17. Beauchemin C., Samuel J., Tuszynski J. A simple cellular automaton model for influenza a viral infections. J. Theor. Biol. 2005, 232:223-234.
18. Beauchemin C.A., Handel A. A review of mathematical models of influenza A infections within a host or cell culture. lessons learned and challenges ahead. BMC Public Health 2011, 11:S7-S21.
19. Beauchemin C.A., McSharry J.J., Drusano G.L., Nguyen J.T., Went G.T., Ribeiro R.M., Perelson A.S. Modeling amantadine treatment of influenza A virus in vitro. J. Theor. Biol. 2008, 254:439-451.
20. Beck M.A., Nelson H.K., Shi Q., Van Dael P., Schiffrin E.J., Blum S., Barclay D., Levander O.A. Selenium deficiency increases the pathology of an influenza virus infection. FASEB J. 2001, 15:1481-1483.
21. Bertram S., Glowacka I., Blazejewska P., Soilleux E., Allen P., Danisch S., Steffen I., Choi S.Y., Park Y., Schneider H., Schughart K., Pohlmann S. TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells. J. Virol. 2010, 84:10016-10025.
22. Bhattarai A., Villanueva J., Palekar R.S., Fagan R., Sessions W., Winter J., Berman L., Lute J., Leap R., Marchbanks T., Sodha S.V., Moll M., Xu X., Fry A., Fiore A., Ostroff S., Swerdlow D.L. Viral shedding duration of pandemic influenza A H1N1 virus during an elementary school outbreak-Pennsylvania, May-June 2009. Clin. Infect. Dis. 2011, 52:S102-S108.
23. Bocharov G.A., Romanyukha A.A. Mathematical model of antiviral immune response. III. Influenza A virus infection. J. Theor. Biol. 1994, 167:323-360.
24. Bonabeau E. Agent-based modeling. methods and techniques for simulating human systems. Proc. Natl. Acad. Sci. USA 2002, 99:7280-7287.
25. Boni M., Gog J., Andreasen V., Feldman M. Epidemic dynamics and antigenic evolution in a single season of influenza A. Proc. R. Soc. London B 2006, 273:1307-1316.
26. Bottcher E., Matrosovich T., Beyerle M., Klenk H.D., Garten W., Matrosovich M. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J. Virol. 2006, 80:9896-9898.
27. Bottcher-Friebertshauser E., Freuer C., Sielaff F., Schmidt S., Eickmann M., Uhlendorff J., Steinmetzer T., Klenk H.D., Garten W. Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. J. Virol. 2010, 84:5605-5614.
28. Brankston G., Gitterman L., Hirji Z., Lemieux C., Gardam M. Transmission of influenza A in human beings. Lancet Infect. Dis. 2007, 7:257-265.
29. Breg J., Van Halbeek H., Vliegenthart J.F.G., Lamblin G., Houvenaghel M.C., Roussel P. Structure of sialyl-oligosaccharides isolated from bronchial mucus glycoproteins of patients (blood group O) suffering from cystic fibrosis. Eur. J. Biochem. 1987, 168:57-68.
30. Cairns H.J., Edney M., Fazekas de St Groth S. Quantitative aspects of influenza virus multiplication. J. Immunol. 1952, 69:155-181.
31. Calder L.J., Wasilewski S., Berriman J.A., Rosenthal P.B. Structural organization of a filamentous influenza A virus. Proc. Natl. Acad. Sci. USA 2010, 107:10685-10690.
32. Canini L., Carrat F. Population modeling of influenza a/h1n1 virus kinetics and symptom dynamics. J. Virol. 2011, 85:2764-2770.
33. Cannell J.J., Zasloff M., Garland C.F., Scragg R., Giovannucci E. On the epidemiology of influenza. Virol. J. 2008, 5:29-31.
34. Carrat F., Vergu E., Ferguson N.M., Lemaitre M., Cauchemez S., Leach S., Valleron A.J. Time lines of infection and disease in human influenza. a review of volunteer challenge studies. Am. J. Epidemiol. 2008, 167:775-785.
35. Castillo-Chavez C., Hethcote H.W., Andreasen V., Levin S.A., Liu W.M. Epidemiological models with age structure, proportionate mixing, and cross-immunity. J. Math. Biol. 1989, 27:233-258.
36. Centanni, E., Savonuzzi, E., 1901. La peste aviaria I & II, Communicazione fatta allaccademia delle scienze mediche e naturali de Ferrara. Accad. Sci. Med. Nat. Ferrara.
37. Chambers T.M., Webster R.G. Defective interfering virus associated with A/Chicken/Pennsylvania/83 influenza virus. J. Virol. 1987, 61:1517-1523.
38. Chan M.C.W., Chan R.W.Y., Yu W.C.L., Ho C.C.C., Chui W.H., Lo C.K., Yuen K.M., Guan Y., Nicholls J.M., Peiris J.S.M. Influenza H5N1 virus infection of polarized human alveolar epithelial cells and lung microvascular endothelial cells. Respir. Res. 2009, 10:102-113.
39. Chen Y., Shiota M., Ohuchi M., Towatari T., Tashiro J., Murakami M., Yano M., Yang B., Kido H. Mast cell tryptase from pig lungs triggers infection by pneumotropic Sendai and influenza A viruses. Eur. J. Biochem. 2000, 267:3189-3197.
40. Christakis N.A., Fowler J.H. Social network sensors for early detection of contagious outbreaks. PLoS One 2010, 5:e12948.
41. Chu C.M., Dawson I.M., Elford W.J. Filamentous forms associated with newly isolated influenza virus. Lancet 1949, 1:602.
42. Cilloniz C., Shinya K., Peng X., Korth M.J., Proll S.C., Aicher L.D., Carter V.S., Chang J.H., Kobasa D., Feldmann F., Strong J.E., Feldmann H., Kawaoka Y., Katze M.G. Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog. 2009, 5:e1000604.
43. Ciofi degli Atti M.L., Merler S., Rizzo C., Ajelli M., Massari M., Manfredi P., Furlanello C., Scalia Tomba G., Iannelli M. Mitigation measures for pandemic influenza in Italy. an individual based model considering different scenarios. PLoS One 2008, 3:e1790.
44. Cohen, L., Xueping, E., Tarsi, J., Ramkumar, T., Horiuchi, T.K., Cochran, R., DeMartino, S., Schechtman, K.B., Hussain, I., Holtzman, M.J., Castro, M., NHLBI Severe Asthma Research Program (SARP), 2011. Epithelial cell proliferation contributes to airway remodeling in severe asthma. Am J Respir Crit Care Med 176, 138-145.
45. Colizza V., Barrat A., Barthelemy M., Valleron A.-J., Vespignani A. Modeling the worldwide spread of pandemic influenza. baseline case and containment interventions. PLoS Med. 2007, 4(January (1)):95-110.
46. Coombs D., Gilchrist M.A., Ball C.L. Evaluating the importance of within- and between-host selection pressures on the evolution of chronic pathogens. Theor. Popul. Biol. 2007, 72:576-591.
47. Couceiro J.N., Paulson J.C., Baum L.G. Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity. Virus Res. 1993, 29:155-165.
48. Cowling B.J., Chan K.H., Fang V.J., Lau L.L., So H.C., Fung R.O., Ma E.S., Kwong A.S., Chan C.W., Tsui W.W., Ngai H.Y., Chu D.W., Lee P.W., Chiu M.C., Leung G.M., Peiris J.S. Comparative epidemiology of pandemic and seasonal influenza A in households. N. Engl. J. Med. 2010, 362:2175-2184.
49. Dahari H., Guedj J., Rong L., Nettles R.E., Cotler S.J., Layden T.J., Perelson A.S. New insights into the mechanism of action of interferon-alfa and BMS-790052. a multiscale mathematical modeling approach. J. Hepatol. 2011, 54S1:312.
50. Daley D.J., Gani J. Epidemic Modeling 1999, Cambridge University Press, New York.
51. Day T., Alizon S., Mideo N. Bridging scales in the evolution of infectious disease life histories. theory. Evolution 2011, 65:3448-3461.
52. De Flora S., Badolati G. Inactivation of A2-Hong Kong influenza virus by heat and by freeze-thawing. Comparison of untreated and gamma-irradiated preparations. Boll. Ist. Sieroter. Milan 1973, 52:293-305.
53. De Flora S., Badolati G. Thermal inactivation of untreated and gamma-irradiated A2-Aichi-2-68 influenza virus. J. Gen. Virol. 1973, 20:261-265.
54. de Vries E., Tscherne D.M., Wienholts M.J., Cobos-Jimenez V., Scholte F., Garcia-Sastre A., Rottier P.J.M., de Haan C.A.M. Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway. PLoS Pathog. 2011, 7:e1001329.
55. Dobrovolny H.M., Baron M.J., Gieschke R., Davies B.E., Jumbe N.L., Beauchemin C.A.A. Exploring cell tropism as a possible contributor to influenza infection severity. PLoS One 2010, 5:e13811.
56. Douglas R.G. Influenza in man. Influenza Viruses and Influenza 1975, 395-418. Academic Press, Inc., New York, NY, USA. E.D. Kilbourne (Ed.).
57. Eames K.T., Webb C., Thomas K., Smith J., Salmon R., Temple J.M. Assessing the role of contact tracing in a suspected H7N2 influenza A outbreak in humans in Wales. BMC Inf. Dis. 2010, 10:141.
58. Eierhoff T., Hrincius E.R., Rescher U., Ludwig S., Ehrhardt C. The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells. PLoS Pathog. 2010, 6:e1001099.
59. Epstein J.M. Modelling to contain pandemics. Nature 2009, 460:687.
60. Epstein J.M., Goedecke D.M., Yu F., Morris R.J., Wagener D.K., Bobashev G.V. Controlling pandemic flu. the value of international air travel restrictions. PLoS One 2007, 2:e401.
61. Esposito S., Daleno C., Baldanti F., Scala A., Campanini G., Taroni F., Fossali E., Pelucchi C., Principi N. Viral shedding in children infected by pandemic A/H1N1/2009 influenza virus. Virol. J. 2011, 8:349.
62. Eubank S., Guclu H., Kumar V.S., Marathe M.V., Srinivasan A., Toroczkai Z., Wang N. Modelling disease outbreaks in realistic urban social networks. Nature 2004, 429:180-184.
63. Feng Z., Xu D., Zhao H. Epidemiological models with non-exponentially distributed disease stages and applications to disease control. Bull. Math. Biol. 2007, 69:1511-1536.
64. Ferguson N., Galvani A., Bush R. Ecological and immunological determinants of influenza evolution. Nature 2003, 422:428-433.
65. Ferguson N.M., Cummings D.A.T., Cauchemez S., Fraser C., Riley S., Meeyai A., Iamsirithaworn S., Burke D.S. Strategies for containing an emerging pandemic in southeast Asia. Nature 2005, 437:209-214.
66. Ferguson N.M., Cummings D.A.T., Fraser C., Cajka J.C., Cooley P.C., Burke D.S. Strategies for mitigating an influenza pandemic. Nature 2006, 442:448-452.
67. Ferm L., Hellander A., Lotstedt P. An adaptive algorithm for simulation of stochastic reaction-diffusion processes. J. Comput. Phys. 2010, 229:343-360.
68. Fraser C., Riley S., Anderson R., Ferguson N. Factors that make an infectious disease outbreak controllable. Proc. Natl. Acad. Sci. USA 2004, 101:6146-6151.
69. Fukuyama S., Kawaoka Y. The pathogenesis of influenza virus infections. the contributions of virus and host factors. Curr. Opin. Immunol. 2011, 23:481-486.
70. Gao R., Dong L., Dong J., Wen L., Zhang Y., Yu H., Feng Z., Chen M., Tan Y., Mo Z., Liu H., Fan Y., Li K., Li C.K., Li D., Yang W., Shu Y. A systematic molecular pathology study of a laboratory confirmed H5N1 human case. PLoS One 2010, 5:e13315.
71. Garcia-Sastre A. Induction and evasion of type I interferon responses by influenza viruses. Virus Res. 2011, 162:12-18.
72. Germann T., Kadau K., Longini I., Macken C. Mitigation strategies for pandemic influenza in the United States. Proc. Natl. Acad. Sci. USA 2006, 103:5935-5940.
73. Getto P., Kimmel M., Marciniak-Czochra A. Modelling and analysis of dynamics of viral infection of cells and of interferon resistance. J. Math. Anal. Appl. 2008, 344:821-850.
74. Ghedin E., Fitch A., Boyne A., Griesemer S., DePasse J., Bera J., Zhang X., Halpin R.A., Smit M., Jennings L., St.George K., Holmes E.C., Spiro D.J. Mixed infection and the genesis of influenza virus diversity. J. Virol. 2009, 83:8832-8841.
75. Gilbert N. Agent-Based Models 2007, Sage Publications, Inc., Thousand Oaks, CA.
76. Gillespie D.T. Stochastic simulation of chemical kinetics. Annu. Rev. Phys. Chem. 2007, 58:35-55.
77. Ginde A.A., Mansbach J.M., Camargo C.A. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 2009, 169:384-390.
78. Ginsberg J., Mohebbi M.H., Patel R.S., Brammer L., Smolinski M.S., Brilliant L. Detecting influenza epidemics using search engine query data. Nature 2009, 457:1012-1014.
79. Girvan M., Callaway D., Newman M., Strogatz S. Simple model of epidemics with pathogen mutation. Phys. Rev. E 2002, 65:031915.
80. Gog J., Grenfell B. Dynamics and selection of many-strain pathogens. Proc. Natl. Acad. Sci. USA 2002, 99:17209-17214.
81. Gog J., Rimmelzwaan G., Osterhaus A., Grenfell B. Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A. Proc. Natl. Acad. Sci. USA 2003, 100:11143-11147.
82. Green I.J. Serial propagation of influenza B (Lee) virus in a transmissible line of canine kidney cells. Science 1962, 138:42-43.
83. Grenfell B.T., Pybus O.G., Gog J.R., Wood J.L., Daly J.M., Mumford J.A., Holmes E.C. Unifying the epidemiological and evolutionary dynamics of pathogens. Science 2004, 303:327-332.
84. Grimm V., Berger U., Bastiansen F., Eliassen S., Ginot V., Giske J., Goss-Custard J., Grand T., Heinz S.K., Huse G., Huth A., Jepsen J.U., Jorgensen C., Mooij W.M., Muller B., Pe'er G., Piou C., Railsback S.F., Robbins A.M., Robbins M.M., Rossmanith E., Ruger N., Strand E., Souissi S., Stillman R.A., Vabo R., Visser U., DeAngelis D.L. A standard protocol for describing individual-based and agent-based models. Ecol. Modeling 2006, 198:115-126.
85. Guarner J., Falcon-Escobedo R. Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses. Arch. Med. Res. 2009, 40:655-661.
86. Guarner J., Shieh W.J., Dawson J., Subbarao K., Shaw M., Ferebee T., Morken T., Nolte K.B., Freifeld A., Cox N., Zaki S.R. Immunohistochemical and in situ hybridization studies of influenza a virus infection in human lungs. Am. J. Clin. Pathol. 2000, 114:227-233.
87. Guedj, J., Dahari, H., Rong, L., Nettles, R.E., Cotler, S.J., Layden, T.J., Perelson, A.S., 2013. Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life. Proc. Natl. Acad. Sci. USA 110, 3991-3996.
88. Guedj J., Neumann A.U. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics. J. Theor. Biol. 2010, 267:330-340.
89. Gustin K., Belser J., Wadford D., Pearce M., Katz J., Tumpey T., Maines T. Influenza virus aerosol exposure and analytical system for ferrets. Proc. Natl. Acad. Sci. USA 2011, 108:8432-8437.
90. Gutierrez, R.A., Viari, A., Godelle, B., Frutos, R., Buchy, P. Biased mutational pattern and quasispecies hypothesis in H5N1 virus. Infect. Genet. Evol., , in press. http://dx.doi.org/10.1016/j.meegid.2011.10.019.
91. Halloran, M.E., Ferguson, N.M., Eubank, S., Longini, Jr., I.M., Cummings, D.A., Lewis B., Xu, S., Fraser, C., Vullikanti, A., Germann, T.C., Wagener, D., Beckman, R., Kadau, K., Barrett, C., Macken, C.A., Burke, D.S., Cooley, P., 2008. Modeling targeted layered containment of an influenza pandemic in the United States. Proc. Natl. Acad. Sci. USA 105, 4639-4644.
92. Hamill, L., Gilbert, N., 2008. A simple but more realistic agent-based model of a social network. In: Proceedings of the European Social Simulation Association Annual Conference.
93. Hancioglu B., Swigon D., Clermont G. A dynamical model of human immune response to influenza A virus infection. J. Theor. Biol. 2007, 246:70-86.
94. Handel A., Longini I.M., Antia R. Neuraminidase inhibitor resistance in influenza. assessing the danger of its generation and spread. PLoS Comput. Biol. 2007, 3:e240.
95. Handel A., Longini I.M., Antia R. Towards a quantitative understanding of the within-host dynamics of influenza A infections. J. R. Soc. Interface 2010, 7:35-47.
96. Hartvigsen G., Dresch J.M., Zielinski A.L., Macula A.J., Leary C.C. Network structure, and vaccination strategy and effort interact to affect the dynamics of influenza epidemics. J. Theor. Biol. 2007, 246:205-213.
97. Haseltine E.L., Lam V., Yin J., Rawlings J.B. Image-guided modeling of virus growth and spread. Bull. Math. Biol. 2008, 70:1730-1748.
98. Haseltine E.L., Rawlings J.B., Yin J. Dynamics of viral infections. incorporating both the intracellular and extracellular levels. Comput. Chem. Eng. 2005, 29:675-686.
99. Haseltine E.L., Yin J., Rawlings J.B. Implications of decoupling the intracellular and extracellular levels in multi-level models of virus growth. Biotechnol. Bioeng. 2008, 101:811-820.
100. Hashimoto Y., Moki T., Takizawa T., Shiratsuchi A., Nakanishi Y. Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice. J. Immunol. 2007, 178:2448-2457.
101. Hatada E., Hasegawa M., Mukaigawa J., Shimizu K., Fukuda R. Control of influenza virus gene expression. quantitative analysis of each viral RNA species in infected cells. J. Biochem. 1989, 105:537-546.
102. Hayden F.G., Fritz R., Lobo M.C., Alvord W., Strober W., Straus S.E. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J. Clin. Invest. 1998, 101:643-649.
103. Heldt F.S., Frensing T., Reichl U. Modeling the intracellular dynamics of influenza virus replication to understand the control of viral RNA synthesis. J. Virol. 2012, 86:7806-7817.
104. Hensley S.E., Das S.R., Bailey A.L., Schmidt L.M., Hickman H.D., Jayaraman A., Viswanathan K., Raman R., Sasisekharan R., Bennink J.R., Yewdell J.W. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 2009, 326:734-736.
105. Hethcote H. The mathematics of infectious diseases. SIAM Rev. 2000, 42:599-653.
106. Hethcote H., Tudor D. Integral-equation models for endemic infectious-diseases. J. Math. Biol. 1980, 9:37-47.
107. Hillaire M.L., van Trierum S.E., Bodewes R., van Baalen C.A., van Binnendijk R.S., Koopmans M.P., Fouchier R.A., Osterhaus A.D., Rimmelzwaan G.F. Characterization of the human CD8+ T cell response following infection with 2009 pandemic influenza H1N1 virus. J. Virol. 2011, 85:12057-12061.
108. Hofmann P., Sprenger H., Kaufmann A., Bender A., Hasse C., Nain M., Gemsa D. Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response. J. Leukoc. Biol. 1997, 61:408-414.
109. Holder B.P., Beauchemin C.A.A. Exploring the effect of biological delays in kinetic models of influenza within a host or cell culture. BMC Public Health 2011, 11.
110. Holmes E., Grenfell B. Discovering the phylodynamics of RNA viruses. PLoS Comput. Biol. 2009, 5:e1000505.
111. Horsfall F.L. Reproduction of influenza viruses; quantitative investigations with particle enumeration procedures on the dynamics of influenza A and B virus reproduction. J. Exp. Med. 1955, 102:441-473.
112. Howat T.J., Barreca C., O'Hare P., Gog J.R., Grenfell B.T. Modelling dynamics of the type I interferon response to in vitro viral infection. J. R. Soc. Interface 2006, 3:699-709.
113. Huang A.S., Baltimore D. Defective viral particles and viral disease processes. Nature 1970, 226:325-327.
114. Huang Y., Zaas A., Rao A., Dobigeon N., Woolf P., Veldman T., Oeien N., McClain M., Varkey J., Nicholson B., Carin L., Kingsmore S., Woods C., Ginsburg G., Hero A. Temporal dynamics of host molecular responses differentiate symptomatic and asymptomatic influenza A infection. PLoS Genet. 2011, 7:e1002234.
115. Hutchinson E.C., von Kirchbach J.C., Gog J.R., Digard P. Genome packaging in influenza A virus. J. Gen. Virol. 2010, 91:313-328.
116. Innes A.L., Woodruff P.G., Ferrando R.E., Donnelly S., Dolganov G.M., Lazarus S.C., Fahy J.V. Epithelial mucin stores are increased in the large airways of smokers with airflow obstruction. Chest 2006, 130:1102-1108.
117. Iverson A.R., Boyd K.L., McAuley J.L., Plano L.R., Hart M.E., McCullers J.A. Influenza virus primes mice for pneumonia from Staphylococcus aureus. J. Infect. Dis. 2011, 203:880-888.
118. Jagger B.W., Wise H.M., Kash J.C., Walters K., Wills N.M., Xiao Y., Dunfee R.L., Schwartzman L.M., Ozinsky A., Bell G.L., Dalton R.M., Lo A., Efstathiou S., Atkins J.F., Firth A.E., Taubenberger J.K., Digard P. An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science 2012, 337:199-204.
119. Johnson C.A., Pekas D.J., Winzler R.J. Neuraminidases and influenza virus infection in embryonated eggs. Science 1964, 143:1051-1052.
120. Kashiwagi T., Hara K., Nakazono Y., Hamada N., Watanabe H. Artificial hybrids of influenza A virus RNA polymerase reveal PA subunit modulates its thermal sensitivity. PLoS One 2010, 5:e15140.
121. Keeling M., Grenfell B. Effect of variability in infection period on the persistence and spatial spread of infectious diseases. Math. Biosci. 1998, 147:207-226.
122. Keeling M.J. The effects of local spatial structure on epidemiological invasions. Proc. R. Soc. London B 1999, 266:859-867.
123. Keeling M.J., Rohani P. Estimating spatial coupling in epidemiological systems. a mechanistic approach. Ecol. Lett. 2002, 5:20-29.
124. Keeling M.J., Rohani P. Modeling Infectious Diseases in Humans and Animals 2008, Princeton University Press, Princeton, NJ, USA.
125. Khan K., Arino J., Hu W., Raposo P., Sears J., Calderon F., Heidebrecht C., M M.M., Liauw J., Chan A., Gardam M. Spread of a novel influenza A (H1N1) virus via global airline transportation. N. Engl. J. Med. 2009, 361:212-214.
126. Khoo U.-S., Chan K.Y.K., Chan V.S.F., Lin C.L.S. DC-SIGN and L-SIGN. the SIGNs for infection. J. Mol. Med. 2008, 86:861-874.
127. Kido H., Yokogoshi Y., Sakai K., Tashiro M., Kishino Y., Fukutomi A., Katunuma N. Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. possible activator of the viral fusion glycoprotein. J. Biol. Chem. 1992, 267:13573-13579.
128. Kilbourne E.D., Murphy J.S. Genetic studies of influenza viruses. I. Viral morphology and growth capacity as exchangeable genetic traits. Rapid in ovo adaptation of early passage asian strain isolates by combination with PR8. J. Exp. Med. 1960, 111:387-406.
129. Kitamura R., Chen C., Pendyala R.M., Narayanan R. Micro-simulation of daily activity-travel patterns for travel demand forecasting. Transportation 2000, 27:25-51.
130. Kitchovitch S., Lio P. Community structure in social networks. applications for epidemiological modelling. PLoS One 2011, 6:e22220.
131. Kobasa D., Jones S.M., Shinya K., Kash J.C., Copps J., Ebihara H., Hatta Y., Kim J.H., Halfmann P., Hatta M., Feldmann F., Alimonti J.B., Fernando L., Li Y., Katze M.G., Feldmann H., Kawaoka Y. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 2007, 445:319-323.
132. Koelle K., Cobey S., Grenfell B., Pascual M. Epochal evolution shapes the phylodynamics of influenza A (H3N2) in humans. Science 2006, 314:1898-1903.
133. Koelle K., Kamradt M., Pascual M. Understanding the dynamics of rapidly evolving pathogens through modeling the tempo of antigenic change. influenza as a case study. Epidemics 2009, 1:129-137.
134. Koelle K., Khatri P., Kamradt M., Kepler T. A two-tiered model for simulating the ecological and evolutionary dynamics of rapidly evolving viruses, with an application to influenza. J. R. Soc. Interface 2010, 7:1257-1274.
135. Kohl C. Alteration of airway wall temperature during different inhalation procedures. J. Aerosol Sci. 1990, 21:S415-S417.
136. Kozul C.D., Ely K.H., Enelow R.I., Hamilton J.W. Low-dose arsenic compromises the immune response to influenza A infection in vivo. Environ. Health Perspect. 2009, 117:1441-1447.
137. Kreijtz J., Fouchier R., Rimmelzwaan G. Immune responses to influenza virus infection. Virus Res. 2011, 162:19-30.
138. Kroeze E., Kuiken T., Osterhaus A. Animal models. Methods Mol. Biol. 2012, 865:127-146.
139. Kuhn C., Wright J.L. The normal lung. Thurlbeck's Pathology of the Lung 2005, 1-37. Thieme Medical Publishers, Inc, (Chapter 1). 3rd edition. A. Churg, J. Myers, H. Tazelaar, J. Wright (Eds.).
140. Kuiken T., Rimmelzwaan G.F., Van Amerongen G., Osterhaus A.D. Pathology of human influenza A (H5N1) virus infection in cynomolgus macaques (Macaca fascicularis). Vet. Pathol. 2003, 40:304-310.
141. Kuiken T., Taubenberger J.K. Pathology of human influenza revisited. Vaccine 2008, 26:D59-D66.
142. La Gruta N.L., Kedzierska K., Stambas J., Doherty P.C. A question of self-preservation. immunopathology in influenza virus infection. Immunol. Cell Biol. 2007, 85:85-92.
143. Lachowicz-Scroggins M.E., Boushey H.A., Finkbeiner W.E., Widdicombe J.H. Interleukin-13-induced mucous metaplasia increases susceptibility of human airway epithelium to rhinovirus infection. Am. J. Respir. Cell Mol. Biol. 2010, 43:652-661.
144. Lai S.K., Wang Y., Cone R., Hanes J. Nanoparticles reveal that human cervical mucus is riddled with pores larger than viruses. Proc. Natl. Acad. Sci. USA 2010, 107:598-603.
145. Lakadamyali M., Rust M.J., Zhuang X. Endocytosis of influenza viruses. Microbes Infect. 2004, 6:929-936.
146. Lam V., Duca K.A., Yin J. Arrested spread of vesicular stomatitis virus infections in vitro depends on interferon-mediated antiviral activity. Biotechnol. Bioeng. 2005, 90:793-804.
147. 1H NMR spectroscopy. J. Biol. Chem. 1984, 259:9051-9058.
148. Lande R., Engen S., Saether B. Extinction times in finite metapopulation models with stochastic local dynamics. OIKOS 1998, 83:383-389.
149. Lange A., Ferguson N.M. Antigenic diversity, transmission mechanisms, and the evolution of pathogens. PLoS Comput. Biol. 2009, 5.
150. Lauring A.S., Andino R. Quasispecies theory and behavior of RNA viruses. PLoS Pathog. 2010, 6:e1001005.
151. Lee H.Y., Topham D.J., Park S.Y., Hollenbaugh J., Treanor J., Mosmann T.R., Jin X., Ward B.M., Miao H., Holden-Wiltse J., Perelson A.S., Zand M., Wu H. Simulation and prediction of the adaptive immune response to influenza A virus infection. J. Virol. 2009, 83:7151-7165.
152. Lemaitre M., Carrat F. Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic. BMC Infect. Dis. 2010, 10:162.
153. Li C.C., Wang L., Eng H.L., You H.L., Chang L.S., Tang K.S., Lin Y.J., Kuo H.C., Lee I.K., Liu J.W., Huang E.Y., Yang K.D. Correlation of pandemic (H1N1) 2009 viral load with disease severity and prolonged viral shedding in children. Emerg. Infect. Dis. 2010, 16:1265-1272.
154. Liao, C.M., Chio, C.P., Cheng, Y.H., Hsieh, N.H., Chen, W.Y., Chen, S.C., 2011. Quantitative links between arsenic exposure and influenza A (H1N1) infection-associated lung function exacerbations risk. Risk Anal. 31, 1281-1294.
155. Lindemann J., Leiacker R., Rettinger G., Keck T. Nasal mucosal temperature during respiration. Clin. Otolaryngol. Allied Sci. 2002, 27:135-139.
156. Lipsitch M., Viboud C. Influenza seasonality. lifting the fog. Proc. Natl. Acad. Sci. USA 2009, 106:3645-3646.
157. Lloyd A. Realistic distributions of infectious periods in epidemic models. changing patterns of persistence and dynamics. Theor. Popul. Biol. 2001, 60:59-71.
158. Lode G., Gruber F. Bakteriologische studien uber die aetiologie einer epidemischen erkrankung der huhner in tirol. Zentbl. Bakt. Parasitkde 1901, 1:593-604.
159. Londrigan S.L., Turville S.G., Tate M.D., Deng Y.M., Brooks A.G., Reading P.C. N-linked glycosylation facilitates sialic acid-independent attachment and entry of influenza A viruses into cells expressing DC-SIGN or L-SIGN. J. Virol. 2011, 85:2990-3000.
160. Lowen A.C., Mubareka S., Steel J., Palese P. Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog. 2007, 3:1470-1476.
161. Luciani F., Alizon S. The evolutionary dynamics of a rapidly mutating virus within and between hosts. the case of hepatitis C virus. PLoS Comput. Biol. 2009, 5.
162. Luo S., Reed M., Mattingly J., Koelle K. The impact of host immune status on the within-host and population dynamics of antigenic immune escape. J. R. Soc. Interface 2012, 9:2603-2613.
163. Maggiora A., Valenti G.L. Su una epizoozia di tifo essudativo dei gallinacei. Accademia medica, Modena, 20 June. Modena 1901.
164. Malato L., Llavador V., Marmier E., Youssef J., Balick Weber C., Roze H., Bessede E., Fleury H.J. Pandemic influenza A(H1N1) 2009. molecular characterisation and duration of viral shedding in intensive care patients in Bordeaux, south-west France, May 2009 to January 2010. Euro Surveill. 2011, 16:19776.
165. Manicassamy B., Manicassamy S., Belicha-Villanueva A., Pisanelli G., Pulendran B., Garcia-Sastre A. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc. Natl. Acad. Sci. USA 2010, 107:11531-11536.
166. Marcus P.I., Ngunjiri J.M., Sekellick M.J. Dynamics of biologically active subpopulations of influenza virus. plaque-forming, noninfectious cell-killing, and defective interfering particles. J. Virol. 2009, 83:8122-8130.
167. Marriott A.C., Dimmock N.J. Defective interfering viruses and their potential as antiviral agents. Rev. Med. Virol. 2010, 20:51-62.
168. Massin P., Kuntz-Simon G., Barbezange C., Deblanc C., Oger A., Marquet-Blouin E., Bougeard S., van der Werf S., Jestin V. Temperature sensitivity on growth and/or replication of H1N1, H1N2 and H3N2 influenza A viruses isolated from pigs and birds in mammalian cells. Vet. Microbiol. 2010, 142:232-241.
169. Matrosovich M.N., Matrosovich T.Y., Gray T., Roberts N.A., Klenk H.D. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc. Natl. Acad. Sci. USA 2004, 101:4620-4624.
170. Matrosovich M.N., Matrosovich T.Y., Gray T., Roberts N.A., Klenk H.D. Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J. Virol. 2004, 78:12665-12667.
171. May R.M. Network structure and the biology of populations. Trends Ecol. Evol. 2006, 21:394-399.
172. McCullers J.A. Insights into the interaction between influenza virus and pneumococcus. Clin. Microbiol. Rev. 2006, 19:571-582.
173. McFadden E.R., Pichurko B.M., Bowman H.F., Ingenito E., Burns S., Dowling N., Solway J. Thermal mapping of the airways in humans. J. Appl. Physiol. 1985, 58:564-570.
174. Medina R.A., Garcia-Sastre A. Influenza A viruses. new research developments. Nat. Rev. Microbiol. 2011, 9:590-603.
175. Merler S., Ajelli M. The role of population heterogeneity and human mobility in the spread of pandemic influenza. Proc. R. Soc. B-Biol. Sci. 2010, 277(February (1681)):557-565.
176. Merler S., Ajelli M., Pugliese A., Ferguson N.M. Determinants of the spatiotemporal dynamics of the 2009 H1N1 pandemic in Europe. implications for real-time modelling. PLoS Comput. Biol. 2011, 7(September (9)).
177. Meschi S., Selleri M., Lalle E., Bordi L., Valli M.B., Ferraro F., Ippolito G., Petrosillo N., Lauria F.N., Capobianchi M.R. Duration of viral shedding in hospitalized patients infected with pandemic H1N1. BMC Infect. Dis. 2011, 23:140.
178. Miao H., Hollenbaugh J.A., Zand M.S., Holden-Wiltse J., Mosmann T.R., Perelson A.S., Wu H.S., Topham D.J. Quantifying the early immune response and adaptive immune response kinetics in mice infected by influenza A virus. J. Virol. 2010, 84:6687-6698.
179. Miao H., Xia X., Perelson A.S., Wu H.S. On identifiability of nonlinear ODE models and applications in viral dynamics. SIAM Rev. Soc. Ind. Appl. Math. 2010, 53:3-39.
180. Mideo N., Alizon S., Day T. Linking within- and between-host dynamics in the evolutionary epidemiology of infectious diseases. Trends Ecol. Evol. 2008, 23:511-517.
181. Mitchell H., Levin D., Forrest S., Beauchemin C.A., Tipper J., Knight J., Donart N., Layton R.C., Pyles J., Gao P., Harrod K.S., Perelson A.S., Koster F. Higher level of replication efficiency of 2009 (H1N1) pandemic influenza virus than those of seasonal and avian strains. kinetics from epithelial cell culture and computational modeling. J. Virol. 2011, 85:1125-1135.
182. Mohler L., Flockerzi D., Sann H., Reichl U. Mathematical model of influenza A virus production in large-scale microcarrier culture. Biotechnol. Bioeng. 2005, 90:46-58.
183. Mok C.K., Lee D.C., Cheung C.Y., Peiris M., Lau A.S. Differential onset of apoptosis in influenza A virus H5N1- and H1N1-infected human blood macrophages. J. Gen. Virol. 2010, 88:1275-1280.
184. Monsalvo A.C., Batalle J.P., Lopez M.F., Krause J.C., Klemenc J., Hernandez J.Z., Maskin B., Bugna J., Rubinstein C., Aguilar L., Dalurzo L., Libster R., Savy V., Baumeister E., Aguilar L., Cabral G., Font J., Solari L., Weller K.P., Johnson J., Echavarria M., Edwards K.M., Chappell J.D., Crowe J.E., Williams J.V., Melendi G.A., Polack F.P. Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat. Med. 2011, 17:195-199.
185. Moradpour D., Penin F., Rice C.M. Replication of hepatitis C virus. Nat. Rev. Microbiol. 2007, 5:453-463.
186. Morens D.M., Taubenberger J.K., Fauci A.S. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza. implications for pandemic influenza preparedness. J. Infect. Dis. 2008, 198:962-970.
187. Mossong J., Hens N., Jit M., Beutels P., Auranen K., Mikolajczyk R., Massari M., Salmaso S., Tomba G.S., Wallinga J., Heijne J., Sadkowska-Todys M., Rosinska M., Edmunds W.J. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008, 5:e74.
188. Murakami M., Towatari T., Ohuchi M., Shiota M., Akao M., Okumura Y., Parry M.A.A., Kido H. Mini-plasmin found in the epithelial cells of bronchioles triggers infection by broad-spectrum influenza A viruses and Sendai virus. Eur. J. Biochem. 2001, 268:1-10.
189. Murphy B.R., Chalhub E.G., Nusinoff S.R., Kasel J., Chanock R.M. Temperature-sensitive mutants of influenza virus. 3. further characterization of the ts-1(E) influenza A recombinant (H3N2) virus in man. J. Infect. Dis. 1973, 128:479-487.
190. Nakajima N., Hata S., Sato Y., Tobiume M., Katano H., Kaneko K., Nagata N., Kataoka M., Ainai A., Hasegawa H., Tashiro M., Kuroda M., Odai T., Urasawa N., Ogino T., Hanaoka H., Watanabe M., Sata T. The first autopsy case of pandemic influenza (A/H1N1pdm) virus infection in Japan. detection of a high copy number of the virus in type ii alveolar epithelial cells by pathological and virological examination. Jpn. J. Infect. Dis. 2010, 63:67-71.
191. Nayak D.P., Tobita K., Janda J.M., Davis A.R., De B.K. Homologous interference mediated by defective interfering influenza virus derived from a temperature-sensitive mutant of influenza virus. J. Virol. 1978, 28:375-386.
192. Newman M.E.J. Assortive mixing in networks. Phys. Rev. Lett. 2002, 89:208701-1-208701-4.
193. Newman M.E.J. Spread of epidemic disease on networks. Phys. Rev. E 2002, 66:016128-1-016128-11.
194. Newman M.E.J. Networks. An Introduction 2010, Oxford University Press, New York, NY, USA.
195. Ng S., Cowling B.J., Fang V.J., Chan K.H., Ip D.K., Cheng C.K., Uyeki T.M., Houck P.M., Peiris J.S.M., Leung G.M. Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus. Clin. Infect. Dis. 2010, 50:707-714.
196. Nicholson K.G. Clinical features of influenza. Semin. Respir. Infect. 1992, 7:26-37.
197. Noda T., Sagara H., Yen A., Takada A., Kida H., Cheng R.H., Kawaoka Y. Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature 2006, 439:490-492.
198. Nunes-Correia I., Eulalio A. Caveolae as an additional route for influenza virus endocytosis in MDCK cells. Cell. Mol. Biol. Lett. 2004, 9:47-60.
199. Nunes-Correia I., Ramalho-Santos J., Nir S., Pedroso de Lima M.C. Interactions of influenza virus with cultured cells. detailed kinetic modeling of binding and endocytosis. Biochemistry 1999, 38:1095-1101.
200. Ocana-Macchi M., Bel M., Guzylack-Piriou L., Ruggli N., Liniger M., McCullough K.C., Sakoda Y., Isoda N., Matrosovich M., Summerfield A. Hemagglutinin-dependent tropism of H5N1 avian influenza virus for human endothelial cells. J. Virol. 2009, 83:12947-12955.
201. Ordonez C.L., Khashayar R., Wong H.H., Fernando R., Wu R., Hyde D.M., Hotchkiss J.A., Zhang Y., Novikov A., Dolganov G., Fahy J.V. Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. Am. J. Respir. Crit. Care Med. 2001, 163:517-523.
202. Overton H.A., Sweet C., Coates D.M., Smith H. Molecular studies of the differential replication at pyrexial temperatures of two influenza viruses differing in virulence for ferrets. Virus Res. 1986, 5:235-251.
203. Palese P., Shaw M.L. Orthomyxoviridae. the viruses and their replication. Fields Virology 2007, 1647-1690. Wolters Kluwer Lippincott Williams and Wilkins, (Chapter 47). 5th edition. D.M. Knipe, P.M. Howley (Eds.).
204. Pang I., Iwasaki A. Inflammasomes as mediators of immunity against influenza virus. Trends Immunol. 2011, 32:34-41.
205. Pawelek K.A., Huynh G.T., Quinlivan M., Cullinane A., Rong L., Perelson A.S. Modeling within-host dynamics of influenza virus infection including immune responses. PLoS Comput. Biol. 2012, 8:e1002588.
206. Perelson A.S., Rong L., Hayden F.G. Combination antiviral therapy for influenza. predictions from modeling of human infections. J. Infect. Dis. 2012, 205:1642-1645.
207. Perrone L.A., Plowden J.K., Garcia-Sastre A., Katz J.M., Tumpey T.M. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog. 2008, 4:e1000115.
208. Pickens, J.A., Gordy, J., Stallknecht, D.E., Tompkins, S.M., 2010. Examining cellular proteases involved in avian influenza hemagglutinin cleavage. In: Poster at: Cell Symposia: Influenza: Translating Basic Insights, Washington, DC, USA.
209. Piwpankaew, Y., Monteerarat, Y., Suptawiwat, O., Puthavathana, P., Uipresertkul, M., Auewarakul, P., 2010. Distribution of viral RNA, sialic acid receptor, and pathology in H5N1 avian influenza patients. APMIS 118, 895-902.
210. Pontow S.E., Kery V., Stahl P.D. Mannose receptor. Int. Rev. Cytol. 1992, 137B:221-244.
211. Rambaut A., Pybus O.G., Nelson M.I., Viboud C., Taubenberger J.K., Holmes E.C. The genomic and epidemiological dynamics of human influenza A virus. Nature 2008, 453:615-U2.
212. Rand D.A. Correlation equations and pair approximations for spatial ecologies. CWI Q. 1999, 12:329-368.
213. Read J.M., Keeling M.J. Disease evolution on networks. the role of contact structure. Proc. R. Soc. London B 2003, 270:699-708.
214. Reading P.C., Miller J.L., Anders E.M. Involvement of the mannose receptor in infection of macrophages by influenza virus. J. Virol. 2000, 74:5190-5197.
215. Regoes R.R., Bonhoeffer S. Emergence of drug-resistant influenza virus. population dynamical considerations. Science 2006, 312:389-391.
216. Richman D.D., Murphy B.R., Baron S., Uhlendorf C. Three strains of influenza A virus (H3N2). interferon sensitivity in vitro and interferon production in volunteers. J. Clin. Microbiol. 1976, 3:223-226.
217. Rimmelzwaan G.F., Kuiken T., van Amerongen G., Bestebroer T.M., Fouchier R.A., Osterhaus A.D. Pathogenesis of influenza A (H5N1) virus infection in a primate model. J. Virol. 2001, 75:6687-6691.
218. Roberts P.C., Compans R.W. Host cell dependence of viral morphology. Proc. Natl. Acad. Sci. USA 1998, 95:5746-5751.
219. Roberts P.C., Lamb R.A., Compans R.W. The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation. Virology 1998, 240:127-137.
220. Rogers D.F. The airway goblet cell. Int. J. Biochem. Cell Biol. 2003, 35:1-6.
221. Rossman J.S., Jing X., Leser G.P., Balannik V., Pinto L.H., Lamb R.A. Influenza virus M2 ion channel protein is necessary for filamentous virion formation. J. Virol. 2010, 84:5078-5088.
222. Rossman J.S., Lamb R.A. Influenza virus assembly and budding. Virology 2011, 411:229-236.
223. Russell C., Fonville J., Brown A., Burke D., Smith D., James S., Herfst S., van Boheemen S., Linster M., Schrauwen E., Katzelnick L., Mosterin A., Kuiken T., Maher E., Neumann G., Osterhaus A., Kawaoka Y., Fouchier R., Smith D. The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science 2012, 336:1541-1547.
224. Russell C.A., Jones T.C., Barr I.G., Cox N.J., Garten R.J., Gregory V., Gust I.D., Hampson A.W., Hay A.J., Hurt A.C., de Jong J.C., Kelso A., Klimov A.I., Kageyama T., Komadina N., Lapedes A.S., Lin Y.P., Mosterin A., Obuchi M., Odagiri T., Osterhaus A.D.M.E., Rimmelzwaan G.F., Shaw M.W., Skepner E., Stohr K., Tashiro M., Fouchier R.A.M., Smith D.J. The global circulation of seasonal influenza A (H3N2) viruses. Science 2008, 320:340-346.
225. Rvachev L.A., Longini I.M. A mathematical model for the global spread of influenza. Math. Biosci. 1985, 75:3-22.
226. Saenz R.A., Quinlivan M., Elton D., MacRae S., Blunden A.S., Mumford J.A., Daly J.M., Digard P., Cullinane A., Grenfell B.T., McCauley J.W., Wood J.L.N., Gog J.R. Dynamics of influenza virus infection and pathology. J. Virol. 2010, 84:3974-3983.
227. Salathe M., Kazandjieva M., Lee J.W., Levis P., Feldman M.W., Jones J.H. A high-resolution human contact network for infectious disease transmission. Proc. Natl. Acad. Sci. USA 2010, 107:22020-22025.
228. Sato M., Yoshida S., Iida K., Tomozawa T., Kido H., Yamashita M. A novel influenza A virus activating enzyme from porcine lung. purification and characterization. Biol. Chem. 2003, 384:219-227.
229. Saxton M.J. Anomalous diffusion due to obstacles. a Monte Carlo study. Biophys. J. 1994, 66:394-401.
230. Saxton M.J. Anomalous diffusion due to binding. a Monte Carlo study. Biophys. J. 1996, 70:1250-1262.
231. Shaman J., Pitzer V.E., Viboud C., Grenfell B.T., Lipsitch M. Absolute humidity and the seasonal onset of influenza in the continental United States. PLoS Biol. 2006, 8:e1000316.
232. Shope R.E. Swine influenza. III. Filtration experiments and etiology. J. Exp. Med. 1931, 54:373-385.
233. Sidorenko Y., Reichl U. Structured model of influenza virus replication in MDCK cells. Biotechnol. Bioeng. 2004, 88:1-14.
234. Sidorenko Y., Schulze-Horsel J., Voight A., Reichl U., Kienle A. Stochastic population balance modeling of influenza virus replication in vaccine production processes. Chem. Eng. Sci. 2008, 63:157-169.
235. Sieczkarski S.B., Whittaker G.R. Characterization of the host cell entry of filamentous influenza virus. Arch. Virol. 2005, 150:1783-1796.
236. Signorini A., Segre A.M., Polgreen P.M. The use of Twitter to track levels of disease activity and public concern in the U.S. during the influenza A H1N1 pandemic. PLoS One 2011, 6:e19467.
237. Simini F., Gonzalez M.C., Maritan A., Barabasi A.-L. A universal model for mobility and migration patterns. Nature 2012, 484:96-100.
238. Slepushkin V.A., Staber P.D., Wang G., McCray P.B., Davidson B.L. Infection of human airway epithelia with H1N1, H2N2, and H3N2 influenza A virus strains. Mol. Ther. 2001, 3:395-402.
239. Smith A.M., Adler F.R., McAuley J.L., Gutenkunst R.N., Ribeiro R.M., McCullers J.A., Perelson A.S. Effect of 1918 PB1-F2 expression on influenza A virus infection kinetics. PLoS Comput. Biol. 2011, 7:e1001081.
240. Smith, A.M., Adler, F.R., McAuley, J.L., Ribeiro, R.M., McCullers, J.A., Perelson, A.S. Kinetics of coinfection with influenza and Streptococcus pneumoniae, submitted for publication.
241. Smith A.M., Perelson A.S. Influenza A virus infection kinetics. quantitative data and models. Wiley Interdiscip. Rev. Syst. Biol. Med. 2011, 3:429-445.
242. Smith A.M., Ribeiro R.M. Modeling the viral dynamics of influenza A virus infection. Crit. Rev. Immunol. 2010, 30:291-298.
243. Smith D., Forrest S., Ackley D., Perelson A. Variable efficacy of repeated annual influenza vaccination. Proc. Natl. Acad. Sci. USA 1999, 96(24):14001-14006.
244. Smith, D., Lapedes, A., Forrest, S., de Jong, J., Osterhaus, A., Fouchier, R., Cox, N., Perelson, A., 2001. Modeling the effects of updating the influenza vaccine on the efficacy of repeated vaccination. In: Osterhaus, A.D.M., Cox, N., Hampson, A.W. (Eds.), Options for the Control of Influenza IV. International Congress Series, vol. 1219. Elsevier Science, pp. 655-660, (4th World Congress on Options for the Control of Influenza, Hersonissos, Greece, September 23-28, 2000).
245. Smith D.J., Lapedes A.S., de Jong J.C., Bestebroer T.M., Rimmelzwaan G.F., Osterhaus A.D., Fouchier R.A. Mapping the antigenic and genetic evolution of influenza virus. Science 2004, 305:371-376.
246. Smith W., Andrewes C.H., Laidlaw P.P. A virus obtained from influenza patients. Lancet 1933, 2:66-68.
247. Stevens J., Blixt O., Glaser L., Taubenberger J.K., Palese P., Paulson J.C., Wilson I.A. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J. Mol. Biol. 2006, 355:1143-1155.
248. Stilianakis N., Perelson A., Hayden F. Emergence of drug resistance during an influenza epidemic. insights from a mathematical model. J. Infect. Dis. 1998, 177:863-873.
249. Stray S.J., Air G.M. Apoptosis by influenza viruses correlates with efficiency of viral mRNA synthesis. Virus Res. 2001, 77:3-17.
250. Sugiura A., Tobita K., Kilbourne E.D. Isolation and preliminary characterization of temperature-sensitive mutants of influenza virus. J. Virol. 1973, 10:639-647.
251. Suzuki Y. Sialobiology of influenza. molecular mechanism of host range variation of influenza viruses. Biol. Pharm. Bull. 2005, 28:399-408.
252. Svajger U., Anderluh M., Jeras M., Obermajer N. C-type lectin DC-SIGN. an adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity. Cell. Signal. 2010, 22:1397-1405.
253. Takiyama A., Wang L., Tanino M., Kimura T., Kawagishi N., Kunieda Y., Katano H., Nakajima N., Hasegawa H., Takagi T., Nishihara H., Sata T., Tanaka S. Sudden death of a patient with pandemic influenza (A/H1N1pdm) virus infection by acute respiratory distress syndrome. Jpn. J. Infect. Dis. 2010, 63:72-74.
254. Tellier R. Review of aerosol transmission of influenza A virus. Emerg. Infect. Dis. 2006, 12:1657-1662.
255. Thitithanyanont A., Engering A., Uiprasertkul M., Ekchariyawat P., Wiboon-ut S., Kraivong R., Limsalakpetch A., Kum-Arb U., Yongvanitchit K., Sa-Ard-Iam N., Rukyen P., Mahanonda R., Kawkitinarong K., Auewarakul P., Utaisincharoen P., Sirisinha S., Mason C.J., Fukuda M.M., Pichyangkul S. Antiviral immune responses in H5N1-infected human lung tissue and possible mechanisms underlying the hyperproduction of interferon-inducible protein IP-10. Biochem. Biophys. Res. Commun. 2010, 398:752-758.
256. Thompson C.I., Barclay W.S., Zambon M.C., Pickles R.J. Infection of human airway epithelium by human and avian strains of influenza A virus. J. Virol. 2006, 80:8060-8068.
257. To K.K., Chan K.H., Li I.W., Tsang T.Y., Tse H., Chan J.F., Hung I.F., Lai S.T., Leung C.W., Kwan Y.W., Lau Y.L., Ng T.K., Cheng V.C., Peiris J.S., Yuen K.Y. Viral load in patients infected with pandemic H1N1 2009 influenza A virus. J. Med. Virol. 2010, 82:1-7.
258. Tomashefski Jr., J.F., Farver, C.F., 2008. Anatomy and histology of the lung. In: Tomashefski Jr., J.F. (Ed.), Dail and Hammar's Pulmonary Pathology, Volume 1: Nonneoplastic Lung Disease, 3rd edition. Springer Science+Business Media, pp. 20-48 (Chapter 2).
259. Towatari T., Ide M., Ohba K., Chiba Y., Murakami M., Shiota M., Kawachi M., Yamada H., Kido H. Identification of ectopic anionic trypsin I in rat lungs potentiating pneumotropic virus infectivity and increased enzyme level after virus infection. Eur. J. Biochem. 2002, 269:2613-2621.
260. Upham J.P., Pickett D., Irimura T., Anders E.M., Reading P.C. Macrophage receptors for influenza A virus. role of the macrophage galactose-type lectin and mannose receptor in viral entry. J. Virol. 2010, 84:3730-3737.
261. Valkenburg S., Rutigliano J., Ellebedy A., Doherty P., Thomas P., Kedzierska K. Immunity to seasonal and pandemic influenza A viruses. Microbes Infect. 2011, 13:489-501.
262. Van Elden L.J.R., Nijhuis M., Schipper P., Schuurman R., Van Loon A.M. Simultaneous detection of influenza viruses A and B using real-time quantitative PCR. J. Clin. Microbiol. 2001, 39:196-200.
263. van Nimwegen E. Influenza escapes immunity along neutral networks. Science 2006, 314:1884-1886.
264. Vergu E., Busson H., Ezanno P. Impact of the infection period distribution on the epidemic spread in a metapopulation model. PLoS One 2010, 5.
265. Viboud C., Alonso W.J., Simonsen L. Influenza in tropical regions. PLoS Med. 2006, 3:468-471.
266. Viboud C., Bjornstad O., Smith D., Simonsen L., Miller M., Grenfell B. Synchrony, waves, and spatial hierarchies in the spread of influenza. Science 2006, 312:447-451.
267. Viemann D., Schmolke M., Lueken A., Boergeling Y., Friesenhagen J., Wittkowski H., Ludwig S., Roth J. H5N1 virus activates signaling pathways in human endothelial cells resulting in a specific imbalanced inflammatory response. J. Immunol. 2011, 186:164-173.
268. von Magnus P. Incomplete forms of influenza virus. Adv. Virus Res. 1954, 2:59-79.
269. Wang C.C., Chen J.R., Tseng Y.C., Hsu C.H., Hung Y.F., Chen S.W., Chen C.M., Khoo K.H., Cheng T.J., Cheng Y.S., Jan J.T., Wu C.Y., Ma C., Wong C.H. Glycans on influenza hemagglutinin affect receptor binding and immune response. Proc. Natl. Acad. Sci. USA 2009, 106:18137-18142.
270. Wang S.F., Huang J.C., Lee Y.M., Liu S.J., Chan Y.J., Chau Y.P., Chong P., Chen Y.M. DC-SIGN mediates avian H5N1 influenza virus infection in cis and in trans. Biochem. Biophys. Res. Commun. 2008, 373:561-566.
271. Wasserman S., Faust K. Social Network Analysis 2009, Cambridge University Press, New York, NY, USA.
272. Watts D.J. The "new" science of networks. Ann. Rev. Sociol. 2004, 30:243-270.
273. Watts D.J., Muhamad R., Medina D.C., Dodds P.S. Multiscale, resurgent epidemics in a hierarchical metapopulation model. Proc. Natl. Acad. Sci. USA 2005, 102:11157-11162.
274. Wearing H.J., Rohani P., Keeling M.J. Appropriate models for the management of infectious diseases. PLoS Med. 2005, 2:e174.
275. Wei Z., McEvoy M., Razinkov V., Polozova A., Li E., Casas-Finet J., Tous G.I., Balu P., Pan A.A., Mehta H., Schenerman M.A. Biophysical characterization of influenza virus subpopulations using field flow fractionation and multiangle light scattering. correlation of particle counts, size distribution and infectivity. J. Virol. Methods 2007, 144:122-132.
276. Wilkinson L., Waterson A.P. The development of the virus concept as reflected in corpora of studies on individual pathogens. 2. The agent of fowl plague-A model virus?. Med. Hist. 1975, 19:52-72.
277. Wright P.F., Neumann G., Kawaoka Y. Orthomyxoviruses. Fields Virology 2007, 1691-1740. Wolters Kluwer Lippincott Williams and Wilkins, (Chapter 48). 5th edition. D.M. Knipe, P.M. Howley (Eds.).
278. Wu H., Kumar A., Miao H., Holden-Wiltse J., Mosmann T.R., Livingstone A.M., Belz G.T., Perelson A.S., Zand M.S., Topham D.J. Modeling of influenza-specific CD8+ T cells during the primary response indicates that the spleen is a major source of effectors. J. Immunol. 2011, 187:4474-4482.
279. Wu J., Wein L., Perelson A. Optimization of influenza vaccine selection. Oper. Res. 2005, 53(3):456-476.
280. Xu Y., Allen L.J.S., Perelson A.S. Stochastic model of an influenza epidemic with drug resistance. J. Theor. Biol. 2007, 248:179-193.
281. Yang Y., Sugimoto J.D., Halloran M.E., Basta N.E., Chao D.L., Matrajt L., Potter G., Kenah E., Longini I.M. The transmissibility and control of pandemic influenza A (H1N1) virus. Science 2009, 326:729-733.
282. Zeng H., Pappas C., Belser J.A., Houser K.V., Zhong W., Wadford D.A., Stevens T., Balczon R., Katz J.M., Tumpey T.M. Human pulmonary microvascular endothelial cells support productive replication of highly pathogenic avian influenza viruses. possible involvement in the pathogenesis of human H5N1 virus infection. J. Virol. 2012, 86:667-678.